John Walker

Active 1824–2026

136
Papers
19,299
Citations
76
h-index
112
i10-index

Citations

Citations per year for John Walker1967: 5 citations1968: 2 citations1969: 2 citations1970: 4 citations1971: 8 citations1972: 4 citations1973: 6 citations1974: 4 citations1975: 4 citations1976: 6 citations1977: 14 citations1978: 12 citations1979: 26 citations1980: 14 citations1981: 23 citations1982: 22 citations1983: 22 citations1984: 27 citations1985: 19 citations1986: 35 citations1987: 37 citations1988: 57 citations1989: 58 citations1990: 54 citations1991: 58 citations1992: 46 citations1993: 43 citations1994: 60 citations1995: 66 citations1996: 52 citations1997: 52 citations1998: 52 citations1999: 53 citations2000: 59 citations2001: 91 citations2002: 71 citations2003: 65 citations2004: 73 citations2005: 73 citations2006: 86 citations2007: 81 citations2008: 110 citations2009: 101 citations2010: 81 citations2011: 100 citations2012: 84 citations2013: 92 citations2014: 82 citations2015: 74 citations2016: 79 citations2017: 90 citations2018: 70 citations2019: 184 citations2020: 228 citations2021: 284 citations2022: 357 citations2023: 303 citations2024: 491 citations2025: 270 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,997 citing papers, 31.9% of this breakdownUnited Kingdom: 479 citing papers, 7.7% of this breakdownChina: 447 citing papers, 7.1% of this breakdownCanada: 339 citing papers, 5.4% of this breakdownGermany: 324 citing papers, 5.2% of this breakdownItaly: 234 citing papers, 3.7% of this breakdownAustralia: 225 citing papers, 3.6% of this breakdownFrance: 220 citing papers, 3.5% of this breakdownNetherlands: 185 citing papers, 3% of this breakdownJapan: 148 citing papers, 2.4% of this breakdownSpain: 147 citing papers, 2.3% of this breakdownSwitzerland: 109 citing papers, 1.7% of this breakdown
0%31.9%Other 22.5%

Fields

  • Medicine31.3%
  • Biochemistry, Genetics and Molecular Biology21.7%
  • Neuroscience19.6%
  • Computer Science6.4%
  • Engineering3.7%
  • Social Sciences3.4%
  • Other13.9%

Topics

  • Memory and Neural Mechanisms3.1%
  • CRISPR and Genetic Engineering3%
  • Neuroscience and Neuropharmacology Research2.5%
  • Cancer Immunotherapy and Biomarkers2.1%
  • RNA Interference and Gene Delivery1.3%
  • Virus-based gene therapy research1.2%
  • Other86.8%

Coauthors

All papers

Open in search
  1. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2022 cited by 429

  2. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sean C. Semple, Gerald Schwank - Nature Biotechnology 2021 cited by 377

  3. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caroline Robert, Alex Menzies, Thierry Lesimple, Michele Maio, Gerald P. Linette, Michael P. Brown, Peter Hersey, Inge Marie Svane, Laurent Mortier, Jacob Schachter, Catherine Barrow, Ragini R. Kudchadkar, Xinni Song, Caroline Dutriaux, Pietro Quaglino, Friedegund Meier, Paola Queirolo, Daniil Stroyakovskiy, Lars Bastholt, B. Guillot, Claus Garbe, Pablo L. Ortiz‐Romero, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Jean‐Philippe Arnault, Philippe Saïag, Carmen Loquai, Frank Meiß, Jan‐Christoph Simon, Gil Bar‐Sela, Vanna Chiarion‐Sileni, Bernard M. Fitzharris, Mike McCrystal, Phillip Parente, Jean‐François Baurain, P. Combemale, Célèste Lebbé, Axel Hauschild, Naoya Yamazaki, Reinhard Dummer, Mohammed Milhem, Marcin Dzienis, John Walker, L. Geoffrois, M.‐T. Leccia, Lutz Kretschmer, Daniel Hendler, Michal Lotem, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Elaine Dunwoodie, Christoph Höeller, L. Machet, Jessica C. Hassel, Geke A.P. Hospers, Maria-Jose Passos, Max Levin, Martin Fehr, Philippa Corrie, Ashita Waterston, Sigrun Hallmeyer, Henrik Schmidt, V. Descamps, J.‐P. Lacour, Carola Berking, Felix Kiecker, Pier Francesco Ferrucci and 32 more - The Lancet Oncology 2021 cited by 389

  4. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret McGrath, Richard Greil, Dietmar Thurnher, Thorsten Fuereder, Martin Burian, Sylvie Rottey, Jean‐Pascal Machiels, Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu, Stephanie Yasmin Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord, Xavier Zasadny, Lionnel Geoffrois, Yungan Tao, Y. Pointreau, Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg, Simon Laban, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini and 90 more - The Lancet Oncology 2024 cited by 210

  5. A Closer Look at the Hippocampus and Memory

    Authors: , , , - Trends in Cognitive Sciences 2017 cited by 288

  6. Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2023 cited by 72

  7. Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors

    Authors: , , , , , - Journal for ImmunoTherapy of Cancer 2020 cited by 82

  8. Direct solutions of sparse network equations by optimally ordered triangular factorization

    Authors: , - IEEE, Proceedings of the IEEE 1967 cited by 808

  9. Generation of precision preclinical cancer models using regulated in vivo base editing

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2023 cited by 31

  10. CRISPRoff enables spatio-temporal control of CRISPR editing

    Authors: , , , , , , , - Nature Communications 2020 cited by 71

  11. Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells

    Authors: , , , , , , , , - Cell chemical biology 2021 cited by 63

  12. THE POLITICS OF AESTHETICS: THE DISTRIBUTION OF THE SENSIBLE

    Authors: - The Art Book 2005 cited by 2,291

  13. Current Status of Veterinary Vaccines

    Authors: , , , , - Clinical Microbiology Reviews 2007 cited by 512

  14. Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 52

  15. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander S. Krupnick, Cassie C. Kennedy, Nisha Mohindra, David P. Foley, Kymberly D. Watt - American Journal of Transplantation 2020 cited by 157

  16. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michal Kiciński, Stefan Suciu, Caroline Robert, Alexander M.M. Eggermont, Thierry Lesimple, Michele Maio, Gerald P. Linette, Laurent Mortier, Inge Marie Svane, Jacob Schachter, Michael P. Brown, Peter Hersey, Catherine Barrow, Ragini R. Kudchadkar, Caroline Dutriaux, Xinni Song, Pietro Quaglino, Paola Queirolo, Friedegund Meier, Daniil Stroyakovskiy, B. Guillot, Pablo L. Ortiz‐Romero, Lars Bastholt, Claus Garbe, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Carmen Loquai, Frank Meiß, Vanna Chiarion‐Sileni, Gil Bar‐Sela, Bernard M. Fitzharris, Philippe Saïag, Jean‐Philippe Arnault, Jan‐Christoph Simon, Rosalie Stephens, Jean‐François Baurain, Célèste Lebbé, P. Combemale, Reinhard Dummer, Axel Hauschild, Phillip Parente, Naoya Yamazaki, Mohammed Milhem, M.‐T. Leccia, L. Geoffrois, Lutz Kretschmer, Elaine Dunwoodie, John Walker, Michal Lotem, Daniel Hendler, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Marcin Dzienis, Geke A.P. Hospers, Marco Siano, Jessica C. Hassel, Philippa Corrie, Maria-Jose Passos, Max Levin, Christoph Höeller, L. Machet, Sigrun Hallmeyer, Ashita Waterston, V. Descamps, Felix Kiecker, Maureen J.B. Aarts, Henrik Schmidt and 34 more - The Lancet Oncology 2021 cited by 72

  17. Comprehensive in vitro characterization of PD-L1 small molecule inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2019 cited by 134

  18. Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event

    Authors: , , , , , - Osteoporosis International 2023 cited by 34

  19. CD71+ erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors

    Authors: , , , , , , - Journal for ImmunoTherapy of Cancer 2023 cited by 30

  20. The Quality of SARS-CoV-2–Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated

    Authors: , , , , , , , , , - The Journal of Immunology 2021 cited by 60

  21. Serial Vagus Nerve Stimulation Functional MRI in Treatment-Resistant Depression

    Authors: , , , , , , , , , , , , - Neuropsychopharmacology 2007 cited by 150

  22. Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor–induced inflammatory arthritis

    Authors: , , , , , , , - Clinical Rheumatology 2019 cited by 68

  23. The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade

    Authors: , , , - Cancer Immunology Immunotherapy 2020 cited by 55

  24. Bioproduction of Conjugated Linoleic Acid by Probiotic Bacteria Occurs In Vitro and In Vivo in Mice

    Authors: , , , - Journal of Nutrition 2006 cited by 207